. . . "oney.com.This device represents a significant advance in artificial heart technology and holds promise for critically ill heart patients who are not candidates for heart transplants due to age or other medical conditions, Daniel Schultz of the FDA said in a statement.The AbioCor system is a two-pound mechanical heart that pumps in place of the patient's diseased heart, which is removed during su" .